Format

Send to

Choose Destination
See comment in PubMed Commons below
Circ Res. 2011 Aug 5;109(4):453-62. doi: 10.1161/CIRCRESAHA.110.239749.

Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Author information

1
McAllister Heart Institute, University of North Carolina at Chapel Hill, 27599-7525, USA.

Abstract

Cardiac hypertrophy develops most commonly in response to hypertension and is an independent risk factor for the development of heart failure. The mechanisms by which cardiac hypertrophy may be reversed to reduce this risk have not been fully determined to the point where mechanism-specific therapies have been developed. Recently, proteases in the calpain family have been implicated in the regulation of the development of cardiac hypertrophy in preclinical animal models. In this review, we summarize the molecular mechanisms by which calpain inhibition has been shown to modulate the development of cardiac (specifically ventricular) hypertrophy. The context within which calpain inhibition might be developed for therapeutic intervention of cardiac hypertrophy is then discussed.

PMID:
21817165
PMCID:
PMC3151485
DOI:
10.1161/CIRCRESAHA.110.239749
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center